Kintara Therapeutics, Inc. (KTRA)
NASDAQ: KTRA · IEX Real-Time Price · USD
0.259
-0.038 (-12.91%)
At close: Jul 2, 2024, 4:00 PM
0.268
+0.009 (3.40%)
After-hours: Jul 2, 2024, 7:59 PM EDT
KTRA's stock price has decreased by -93.73% in the past year and price targets may not have had time to catch up.
Kintara Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$14.00
Upside
+5,303.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +5,303.32% | Jul 14, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 29, 2022 |
| Dawson James | Dawson James | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $300 → $150 | Strong Buy | Maintains | $300 → $150 | +57,792.71% | Jan 20, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Sep 30, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 28, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Feb 3, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 14, 2020 |